RE:RE:RE:RE:RE:RE:RE:PwC sees continuation of US$ 5 to 15 Billion Bio M&A DealsMay 03, 2024 - The proportion of US$ 10 Blillion deals are increasing versus the US$ 5 Billion "bolt-on" deals. (10:35 timestamp)
More competition for late stage biotech companies resulting in premium prices. (13:30 timestamp)
https://www.fiercepharma.com/deals/closer-look-2023s-top-biopharma-deals-and-what-lies-ahead